Article Details

ADVL2111: Bispecific Antibody Therapy for Acute Myeloid Leukemia (AML)

Retrieved on: 2022-07-12 17:25:50

Tags for this article:

Click the tags to see associated articles and topics

ADVL2111: Bispecific Antibody Therapy for Acute Myeloid Leukemia (AML). View article details on hiswai:

Excerpt

Activating the immune system to attack AML may provide an alternative method of achieving remission. This research study evaluates a CD33xCD3 ...

Article found on: www.stjude.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up